SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 570.05 |
| Enterprise Value ($M) | 495.91 |
| Book Value ($M) | 55.06 |
| Book Value / Share | 0.27 |
| Price / Book | 10.35 |
| NCAV ($M) | 37.41 |
| NCAV / Share | 0.18 |
| Price / NCAV | 15.24 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.74 |
| Return on Assets (ROA) | -0.57 |
| Return on Equity (ROE) | -1.61 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.35 |
| Current Ratio | 5.35 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 120.71 |
| Assets | 138.36 |
| Liabilities | 83.30 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 8.33 |
| Operating Income | -86.62 |
| Net Income | -89.30 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -81.22 |
| Cash from Investing | -0.36 |
| Cash from Financing | 76.68 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Manning Paul B | 9.80 | 9.05 | |
| 13G/A | Rtw Investments, Lp | 9.99 | 67.15 | |
| 13G/A | Fmr Llc | 8.00 | -12.38 | |
| 13G | Octagon Capital Advisors LP | 5.10 | ||
| 13G | Morgan Stanley | 8.60 | ||
| 13G/A | Ra Capital Management, L.p. | 9.99 | 15.37 | |
| 13G | Avoro Capital Advisors LLC | 9.99 | ||
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 4.40 | -13.57 | |
| 13G | BlackRock, Inc. | 6.60 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 830,448 | 3,937,561 | 21.09 | |
| 1,452,346 | 5,599,243 | 25.94 | |
| 800,605 | 3,156,898 | 25.36 | |
| 1,101,961 | 4,783,580 | 23.04 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TLRY – Tilray Brands, Inc. | TNYA – Tenaya Therapeutics, Inc. |
| TRML – Tourmaline Bio, Inc. | TWST – Twist Bioscience Corporation |
| TXMD – TherapeuticsMD, Inc. |
Financial data and stock pages provided by
Fintel.io